Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non–ST‐Segment–Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial

BACKGROUND: The optimal timing of invasive examination and treatment of high‐risk patients with non–ST‐segment–elevation acute coronary syndrome has not been established. We investigated the efficacy of early invasive coronary angiography compared with standard‐care invasive coronary angiography on...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Jawad H., Kofoed, Klaus F., Kelbæk, Henning, Hansen, Peter R., Torp‐Pedersen, Christian, Høfsten, Dan, Holmvang, Lene, Pedersen, Frants, Bang, Lia E., Sigvardsen, Per E., Clemmensen, Peter, Linde, Jesper J., Heitmann, Merete, Hove, Jens Dahlgaard, Abdulla, Jawdat, Gislason, Gunnar, Engstrøm, Thomas, Køber, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649124/
https://www.ncbi.nlm.nih.gov/pubmed/34585591
http://dx.doi.org/10.1161/JAHA.121.022333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649124/
https://www.ncbi.nlm.nih.gov/pubmed/34585591
http://dx.doi.org/10.1161/JAHA.121.022333

Ejemplares similares